Cargando…

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study

Detalles Bibliográficos
Autores principales: Strati, Paolo, de Vos, Sven, Ruan, Jia, Maddocks, Kami J., Flowers, Christopher R., Rule, Simon, Patel, Priti, Xu, Yan, Wei, Helen, Frigault, Melanie M., Calvo, Roser, Dyer, Martin J.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485664/
https://www.ncbi.nlm.nih.gov/pubmed/34233448
http://dx.doi.org/10.3324/haematol.2021.278654
_version_ 1784577580541673472
author Strati, Paolo
de Vos, Sven
Ruan, Jia
Maddocks, Kami J.
Flowers, Christopher R.
Rule, Simon
Patel, Priti
Xu, Yan
Wei, Helen
Frigault, Melanie M.
Calvo, Roser
Dyer, Martin J.S.
author_facet Strati, Paolo
de Vos, Sven
Ruan, Jia
Maddocks, Kami J.
Flowers, Christopher R.
Rule, Simon
Patel, Priti
Xu, Yan
Wei, Helen
Frigault, Melanie M.
Calvo, Roser
Dyer, Martin J.S.
author_sort Strati, Paolo
collection PubMed
description
format Online
Article
Text
id pubmed-8485664
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-84856642021-10-18 Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study Strati, Paolo de Vos, Sven Ruan, Jia Maddocks, Kami J. Flowers, Christopher R. Rule, Simon Patel, Priti Xu, Yan Wei, Helen Frigault, Melanie M. Calvo, Roser Dyer, Martin J.S. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-07-08 /pmc/articles/PMC8485664/ /pubmed/34233448 http://dx.doi.org/10.3324/haematol.2021.278654 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Strati, Paolo
de Vos, Sven
Ruan, Jia
Maddocks, Kami J.
Flowers, Christopher R.
Rule, Simon
Patel, Priti
Xu, Yan
Wei, Helen
Frigault, Melanie M.
Calvo, Roser
Dyer, Martin J.S.
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title_full Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title_fullStr Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title_full_unstemmed Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title_short Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
title_sort acalabrutinib for treatment of diffuse large b-cell lymphoma: results from a phase ib study
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485664/
https://www.ncbi.nlm.nih.gov/pubmed/34233448
http://dx.doi.org/10.3324/haematol.2021.278654
work_keys_str_mv AT stratipaolo acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT devossven acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT ruanjia acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT maddockskamij acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT flowerschristopherr acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT rulesimon acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT patelpriti acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT xuyan acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT weihelen acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT frigaultmelaniem acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT calvoroser acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy
AT dyermartinjs acalabrutinibfortreatmentofdiffuselargebcelllymphomaresultsfromaphaseibstudy